Prostate Cancer Academy 2017 Summaries.
作者信息
Volkin Dmitry
机构信息
Department of Urology, NYU Medical Center New York, NY.
出版信息
Rev Urol. 2017;19(4):252-260. doi: 10.3909/riu0783.
Abstract
摘要
相似文献
1
Prostate Cancer Academy 2017 Summaries.
Rev Urol. 2017;19(4):252-260. doi: 10.3909/riu0783.
2
Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance Imaging.
J Urol. 2018 Mar;199(3):726-733. doi: 10.1016/j.juro.2017.09.033. Epub 2017 Sep 12.
3
Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer.
Technol Cancer Res Treat. 2017 Dec;16(6):1194-1201. doi: 10.1177/1533034617741797. Epub 2017 Dec 5.
4
Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study.
J Urol. 2018 Jul;200(1):95-103. doi: 10.1016/j.juro.2018.01.079. Epub 2018 Feb 1.
5
Integrated 68Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging.
Urol Int. 2018;100(2):164-171. doi: 10.1159/000484695. Epub 2018 Jan 25.
6
Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer.
J Urol. 2019 Aug;202(2):413-421. doi: 10.1097/JU.0000000000000200. Epub 2019 Jul 8.
7
The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade Prostate Cancer: An F-MISO PET-MRI Study.
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1210-1218. doi: 10.1016/j.ijrobp.2018.02.170. Epub 2018 Mar 8.
8
F-Choline Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for the Detection of Early Local Recurrence of Prostate Cancer Initially Treated by Radiation Therapy: Comparison With Systematic 3-Dimensional Transperineal Mapping Biopsy.
Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):986-994. doi: 10.1016/j.ijrobp.2016.12.025. Epub 2016 Dec 28.
9
New advances in focal therapy for early stage prostate cancer.
Expert Rev Anticancer Ther. 2017 Aug;17(8):737-743. doi: 10.1080/14737140.2017.1345630. Epub 2017 Jun 28.
10
Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer.
J Urol. 2016 Oct;196(4):1261-7. doi: 10.1016/j.juro.2016.02.3000. Epub 2016 May 21.
引用本文的文献
1
Preserving Independent Urology: LUGPA's First Decade.
Rev Urol. 2019;21(2-3):102-108.
本文引用的文献
1
Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.
Theranostics. 2017 Apr 10;7(6):1770-1780. doi: 10.7150/thno.18421. eCollection 2017.
2
Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer.
Eur Urol. 2017 Jun;71(6):874-882. doi: 10.1016/j.eururo.2016.11.024. Epub 2016 Dec 12.
3
Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer.
J Clin Oncol. 2016 Aug 20;34(24):2835-42. doi: 10.1200/JCO.2016.67.4788. Epub 2016 Jun 20.
4
Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate Cancer.
J Urol. 2016 Mar;195(3):612-8. doi: 10.1016/j.juro.2015.09.072. Epub 2015 Sep 25.
5
Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
Eur Urol. 2016 Mar;69(3):512-7. doi: 10.1016/j.eururo.2015.06.005. Epub 2015 Jun 22.
6
Dose-Escalated Robotic SBRT for Stage I-II Prostate Cancer.
Front Oncol. 2015 Apr 7;5:48. doi: 10.3389/fonc.2015.00048. eCollection 2015.
7
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.
J Clin Oncol. 2015 Mar 10;33(8):944-51. doi: 10.1200/JCO.2014.59.0026. Epub 2015 Feb 9.
8
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
N Engl J Med. 2014 Sep 11;371(11):1028-38. doi: 10.1056/NEJMoa1315815. Epub 2014 Sep 3.
9
Enzalutamide in metastatic prostate cancer before chemotherapy.
N Engl J Med. 2014 Jul 31;371(5):424-33. doi: 10.1056/NEJMoa1405095. Epub 2014 Jun 1.
10
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Eur Urol. 2014 Sep;66(3):550-60. doi: 10.1016/j.eururo.2014.05.004. Epub 2014 May 16.
Zotero 插件